PRESS RELEASES

Lonza Acquires Cell and Gene Contract

Basel, Switzerland, 30 May 2017 – On 3 May 2017, Lonza successfully completed the acquisition of PharmaCell B.V., one of the most-respected cell and gene contract...

Diabetes with pancreas organoids

Maastricht – May 10, 2016 – The innovations introduced by LSFM4LIFE strengthen the leadership of Europe in the field of advanced therapies and, in particular, in cell-based therapies....

ImmunoCellular Therapeutics chooses PharmaCell

ImmunoCellular Therapeutics chooses PharmaCell as Contract Manufacturing partner for its Phase III program in Europe Maastricht – March 19, 2015 – PharmaCell B.V. a leading Contract Manufacturing...

Innovative solutions for bioproduction

Innovative solutions for bioproduction The Biomaterials Innovation Network Biomat-IN supports the cooperation of InnoCyte and PharmaCell on the future market of the bioproduction of cells and...

PharmaCell to purchase cell therapy production facility from TiGenix

Maastricht – January 23rd, 2014 – PharmaCell B.V. a leading Contract Manufacturing Organization for Cellular Therapies and Regenerative Medicine in Europe, announced today that it has...

PharmaCell Announces Agreement To Be The European Contract Manufacturing Organization for Dendreon

Maastricht, The Netherlands, October 23rd, 2013 – PharmaCell announced today that it has entered into an agreement with Dendreon Corporation (NASDAQ: DNDN) to be the Contract...

Grant to help more scientists enter new field of medical research

October 8, 2013 A scientist working at the Royal Free Hospital has been awarded a grant of £422,000 to help other academics develop medicines made from human...

EMD Millipore and PharmaCell to Develop Optimized Large-Scale Expansionand Harvesting of HepaRG® Cells Grown from Bioreactors

May 21, 2013 EMD Millipore and PharmaCell to Develop Optimized Large-Scale Expansion and Harvesting of HepaRG® Cells Grown from Bioreactors Collaboration to evaluate EMD Millipore’s Mobius®...